51872 Federal Register / Vol. 62, No. 192 / Friday, October 3, 1997 / Notices

Where To Obtain Additional

Information

To receive additional written

information call (404) 332–4561. You

will be asked to leave your name,

address, and telephone number and will

need to refer to announcement #811.

You will receive a complete program

description, information on application

procedures, and application. Business

management information may be

obtained from Joanne Wojcik, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., MS–E13,

Atlanta, GA 30305, telephone (404)

842–6535; fax: (404) 842–6513; Internet:

jcw6@cdc.gov.

Programmatic technical assistance

may be obtained from Roy M. Fleming,

Sc.D., Associate Director for Grants,

National Institute for Occupational

Safety and Health, Centers for Disease

Control and Prevention (CDC), 1600

Clifton Road, NE., Building 1, Room

3053, MS–D30, Atlanta, GA 30333,

telephone: (404) 639–3343; fax: (404)

639–4616; Internet: rmf2@cdc.gov.

Please refer to announcement number

811 when requesting information and

submitting an application.

This and other CDC Announcements

can be found on the CDC home page

(http://www.cdc.gov) under the

Funding section.

CDC will not send application kits by

facsimile or express mail (even at the

request of the applicant).

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

Dated: September 29, 1997.

Linda Rosenstock,

Director, National Institute for Occupational

Safety and Health, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 97–26275 Filed 10–2–97; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

The Centers for Disease Control and

Prevention (CDC) Announces the

Following Workshop

Name: Workshop on Enhancing

Community Participation to Restore

Public Trust and Improve Science in

Health Research.

Times and Dates: 8:30 a.m.–5:30 p.m.,

October 16, 1997. 8 a.m.–4:45 p.m.,

October 17, 1997.

Place: CDC, Auditorium A, 1600

Clifton Road, NE, Atlanta, Georgia

30333.

Status: Open to the public, limited

only by the space available. The meeting

room accommodates approximately 100

people.

Purpose: The primary purpose of this

workshop is to provide guidance to

public health researchers on the

inclusion of communities in the

planning, conduct, and application of

research.

History has demonstrated, when

medical and public health science is

planned and conducted in the absence

of considering the social context of its

work, people have been harmed. As a

result, society has responded with laws

and regulations to protect human

subjects who participate in research.

Lacking in this discussion has been the

issue of planning and conducting

research that involves and impacts

communities. This workshop will

provide a unique opportunity to open

dialogue between government,

communities, and researchers. This

dialogue should result in a proposed

framework through which CDC

promotes public health, advances

democratic principles, establishes an

ethical basis for community-based

research, enhances scientific credibility,

and provides mechanisms for building

public trust while advancing the science

of public health.

Matters To Be Discussed: Agenda

items include: identifying strategies for

partnering with communities in

research and overcoming distrust;

legacy from the Tuskegee Study of

Untreated Syphilis; review of human

subjects protection; role of the

community in protecting human

subjects; assets that communities bring

to research; and assets that researchers

bring to communities.

After the above comments and

discussions, the workshop will be

divided into five breakout sessions

which will include: (I) Strategies, Issues,

and Barriers; (II) Research Design

Scenarios; (III) Critique of Strategies

Elicited in Breakout Session II; (IV)

Community Concerns and Issues; and

(V) Final Recommendations.

Contact Persons for More Information:

Michael J. Sage, Deputy Chief, Radiation

Studies Branch, Division of

Environmental Hazards and Health

Effects, National Center for

Environmental Health, CDC, 4770

Buford Highway, NE (F–35), Atlanta,

Georgia 30341–3724, telephone 770/

488–7040, FAX 770/488–7044; or Kate

M. MacQueen, Ph.D., Division of HIV/

AIDS Prevention, National Center for

HIV, STD and TB Prevention, CDC, 1600

Clifton Road, NE (E–45), Atlanta,

Georgia 30333, telephone 404/639–

6146, FAX 404/639–6129.

Dated: September 29, 1997.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 97–26243 Filed 10–2–97; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 97N–0401]

Agency Information Collection

Activities; Submission for OMB

Review; Comment Request

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that the proposed collection of

information listed below has been

submitted to the Office of Management

and Budget (OMB) for review and

clearance under the Paperwork

Reduction Act of 1995 (the PRA).

DATES: Submit written comments on the

collection of information by November

3, 1997.

ADDRESSES: Submit written comments

on the collection of information to the

Office of Information and Regulatory

Affairs, OMB, New Executive Office

Bldg., 725 17th St. NW., rm. 10235,

Washington, DC 20503, Attn: Desk

Officer for FDA.

FOR FURTHER INFORMATION CONTACT:

Margaret R. Wolff, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1223.